Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.14 | N/A |
| PEG Ratio (TTM) | -0.41 | N/A |
| P/S Ratio (TTM) | 0.76 | N/A |
| P/B Ratio (TTM) | 1.46 | N/A |
| P/FCF Ratio (TTM) | 7.07 | N/A |
| Price to 5YR AVG Earnings Ratio | 8.96 | N/A |
| Price to 5YR AVG FCF Ratio | 17.43 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.79% | N/A |
| ROE (TTM) | 10.17% | N/A |
| Net Profit Margin (TTM) | 5.35% | N/A |
| ROIC 5YR AVG | 21.37% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7.30% | 242.38% | 176.35% |
| Revenue | -2.17% | 14.10% | 32.90% |
| Net Income | 7.37% | 263.34% | 190.56% |
| Cash Flow | -8.67% | 83.24% | 97.53% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.35 | N/A |
| Quick Ratio (TTM) | 0.86 | N/A |
| D/E Ratio (TTM) | 0.23 | N/A |
| Interest Coverage (TTM) | 7.74 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.72 | N/A |
| LTL to 5YR AVG FCF | 1.27 | N/A |
| Shares Outstanding Growth 5YR AVG | 4.74% | N/A |